Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AAD-2004 by GNT Pharma for Amyotrophic Lateral Sclerosis: Likelihood of Approval
AAD-2004 is under clinical development by GNT Pharma and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...